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A quarter of a century after AIDS 
became known as a frightening new 
disease, substantial progress has been 
attained on treatments that convert 
this once certain death sentence into 
a manageable chronic disease. While 
some prevention successes have been 
attained (e.g., screening of the blood 
supply in industrialized countries), a 
safe and effective vaccine—the “holy 
grail” of public health prevention—re-
mains elusive. 
In the late 1990s, the ﬁ  rst HIV 
vaccine taken to phase III trial, the 
VaxGen gp120 vaccine (VaxGen, 
Brisbane, CA, USA), became the basis 
for substantial debate and controversy 
between empiricists (generally public 
health persons who believed that the 
urgency of the pandemic required tak-
ing some risks, including a potentially 
low-efﬁ   cacy vaccine as a ﬁ  rst  step) 
and reductionists (generally basic sci-
entists and researchers who felt that the 
gp120 vaccine was unlikely to work 
given our state of knowledge and who 
wanted to wait for a better candidate 
vaccine). With trial results now avail-
able, we know that this vaccine was 
not efﬁ  cacious. We also know that a 
phase III trial, although challenging to 
organize and conduct among persons 
at high risk, is doable. What else we 
do and do not know scientiﬁ  cally is 
summarized nicely in the 19 chapters 
of this excellently edited, concise (150 
pages), softbound book.
The book is organized into 5 
parts: Global Overview; What Does 
a Vaccine Need to Do?; Preclinical 
Development: Design Challenges; 
Clinical Trials; and From Testing to 
Deployment. Each chapter, written by 
experts in each ﬁ  eld, is impressive in 
its balance of compactness (3–4 dou-
ble-sided pages, including references), 
technical content, and user-friendli-
ness (abstract and conclusion for each 
chapter make quick review easy). 
The authors and editors are to be 
commended for bringing each of the 
key topics relevant to HIV vaccines to 
the reader in a highly accessible form. 
Key topics include HIV pathogenesis; 
the twists and turns of what speciﬁ  c 
knowledge of simian immunodeﬁ  -
ciency virus and nonhuman primates 
is or is not applicable to HIV and hu-
mans; and the highly technical nature 
of modern immunology, virology, and 
structural biology. The editors were 
careful to include chapters on impor-
tant nonscientiﬁ  c aspects of HIV vac-
cine development, such as clinical site 
development, regulatory issues, scale-
up, and manufacturing.
This book provides an excellent 
introductory overview for the begin-
ning HIV vaccine researcher or any 
person who needs a more technical 
primer on the various aspects of the 
HIV vaccine challenge. The number 
of HIV vaccine researchers is now  in-
creasing, given the support of several 
organizations (e.g., Bill and Melinda 
Gates Foundation) and collaborations 
(e.g., Global HIV Vaccine Enterprise, 
the Partnership for AIDS Vaccine 
Evaluation, and the Center for HIV-
AIDS Vaccine Immunology). These 
organizations, collaborations, and 
researchers are attempting to better 
organize the human and technical re-
sources needed to challenge this for-
midable foe on the scale of the Man-
hattan Project or the March of Dimes 
search for a polio vaccine. Let us hope 
that they will eventually succeed.
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Bird Flu: A Virus of Our Own 
Hatching, by Michael Gerber, MD, 
is written for a nonprofessional audi-
ence. A professional audience would 
quickly put it aside for more factually 
correct sources of information.
Dr. Gerber is the director of Pub-
lic Health and Animal Agriculture at 
the Humane Society of the United 
States. Much of the book is devoted to 
criticism of the commercial farming of 
1802  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 11, November 2007
Search past issues of EID at www.cdc.gov/eidbirds and other animals; agricultural practices are blamed 
for the threat of pandemic inﬂ  uenza. He neglects the fact 
that most of the cases of human infection with inﬂ  uenza A 
(H5N1) have come from family farms in Asia, rather than 
the large commercial ventures.
The science relating to the current subtype H6N1 is 
changing so rapidly that any book is out-of-date by the time 
it is published. The book contains 90 pages of references, 
mostly from the popular press. Few current peer-reviewed 
sources are cited.
The need for authoritative information on avian inﬂ  u-
enza (H5N1) for the lay public is great, but unfortunately, 
this book does not meet that need. It focuses heavily on 
doomsday scenarios and offers little in terms of practical 
advice to the public. For those interested in the book, it can 
be found online at www.birdﬂ  ubook.com.
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BOOKS & MEDIA   ANOTHER DIMENSION
A Country Story
Kenneth Fields
“When I was a little girl back in East Texas,”
My mother’s mother, Beulah, used to tell,
“There was an outbreak of the German measles,
Mama was pregnant, so I went away
To a neighbor lady’s, three or four miles from home
When the ﬁ  rst signs showed. I was just eight, and sick,
And lonesome for Mama. One day she came for me.
My little sister had broken out, and Mama 
Figuring she would die, and the baby, too,
Wanted us all together for those last weeks.
She wanted me home with her. As it turned out
My sister had been reading by the ﬁ  re
And broke out from the heat, and it was me
That carried the measles home. After Mama died
I used to think of seeing her out the window
Talking to the neighbor lady on that day,
Crying and wiping her eyes with her apron hem.”
From Classic Rough News. © The University of Chicago 
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